Injectable high blood pressure treatments in development show potential for up to six-month control, offering a new drug class and improved adherence.

Injectable treatments for high blood pressure are in development, with recent clinical trials showing their potential to control blood pressure for up to six months. If approved, these injectables could become the first new drug class for hypertension in decades. They may offer a more convenient alternative to daily pills, improving adherence to treatment and achieving long-lasting reductions in blood pressure.

July 14, 2024
4 Articles